Impact of long-term combination lipid-lowering therapy on plaque vulnerability in patients with acute coronary syndrome
Aim. To evaluate the potential of high-dose combination lipid-lowering therapy (LLT) in reducing coronary atherosclerosis in patients after acute coronary syndrome (ACS), depending on the presence of vulnerable plaques (VPs). Material and methods . The study included 125 patients (men, 68%; mean age, 56,9±9,8...